Diseases [C] » Neoplasms [C04] » Neoplasms by Histologic Type » Neoplasms, Glandular and Epithelial » Carcinoma » Adenocarcinoma » Adenocarcinoma of Lung
Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Thoracic Neoplasms » Respiratory Tract Neoplasms » Lung Neoplasms » Adenocarcinoma of Lung
Description
A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer. MeSH
Hierarchy View
Subtype Terms (1)
Adenocarcinoma, Bronchiolo-Alveolar
7 drugs (6 approved, 1 experimental)
Phase 4 Indicated Drugs (5)
Phase 2 Indicated Drugs (31)
Other Experimental Indicated Drugs (5)
Organization Involved with Phase 4 Indications (8)
Organization Involved with Phase 3 Indications (23)
Chinese Academy of Medical Sciences
Eastern Cooperative Oncology Group
Groupe Francais De Pneumo-Cancerologie
Organization Involved with Phase 2 Indications (91)
City of Hope National Medical Center
ECOG-ACRIN Cancer Research Group
Europejskie Centrum Zdrowia Otwock
First People's Hospital of Hangzhou
Groupe Hospitalier Paris Saint Joseph
Guangdong Province Association Study of Thoracic Oncology
Hoosier Cancer Research Network
Intergroupe Francophone de Cancerologie Thoracique
National Natural Science Foundation of China
Puyang Oil Field General Hospital
Organization Involved with Phase 1 Indications (11)
Organization Involved with Other Experimental Indications (7)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.